Results 261 to 270 of about 1,645,777 (287)

The oncologic burden of hepatitis C virus infection: A clinical perspective

Ca-A Cancer Journal for Clinicians, 2017
Harrys A Torres, Roy F Chemaly, Nassim Hammoudi   +2 more
exaly  

Long-Acting Cabotegravir and Rilpivirine after Oral Induction for HIV-1 Infection

New England Journal of Medicine, 2020
Chloe Orkin, Sharon L Walmsley, Christopher Bettacchi   +2 more
exaly  

Intermodal Surface Transportation Efficiency Act

2014
openaire   +1 more source

Long-Acting Cabotegravir and Rilpivirine for Maintenance of HIV-1 Suppression

New England Journal of Medicine, 2020
Susan Swindells, Giuliano Rizzardini, Mar Masiá   +2 more
exaly  

Effect of long-acting and short-acting calcium antagonists on cardiovascular outcomes in hypertensive patients

Lancet, The, 1997
Hillel W Cohen
exaly  

Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study

Lancet, The, 2019
Fabrice Carrat, Hélène Fontaine, Victor de Lédinghen   +2 more
exaly  

On nilpotent groups acting on Klein surfaces

1991
Emilio Bujalance, Grzegorz Gromadzki
openaire   +1 more source

Long-acting intramuscular cabotegravir and rilpivirine in adults with HIV-1 infection (LATTE-2): 96-week results of a randomised, open-label, phase 2b, non-inferiority trial

Lancet, The, 2017
Juan J González-García, Joseph J Eron, Daniel Podzamczer   +2 more
exaly  

Regulation of gene expression by cis-acting long non-coding RNAs

Nature Reviews Genetics, 2019
Igor Ulitsky
exaly  

Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting β2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial

Lancet, The, 2016
Sally E Wenzel, Mario Castro, Jonathan Corren   +2 more
exaly